Nexalin Technology (NXL) Non-Current Assets (2021 - 2026)
Nexalin Technology (NXL) posted quarterly Non-Current Assets of $404479.0 for Q1 2026, up 44.7% year-over-year from $279520.0 in Q1 2025, and up 20.36% quarter-over-quarter from $336049.0 in Q4 2025.
Nexalin Technology (NXL) Non-Current Assets (2021 - 2026) Analysis & Trends
Nexalin Technology's Non-Current Assets history runs 6 years deep, the most recent figure standing at $404479.0 for Q1 2026.
- In Q1 2026, Non-Current Assets rose 44.7% year-over-year to $404479.0; the TTM figure through Mar 2026 stood at $1.3 million (up 5.68% YoY), while the FY2025 annual figure was $336049.0, up 28.46% from the prior year.
- Non-Current Assets for Q1 2026 stood at $404479.0, up from $336049.0 in the prior quarter.
- The five-year high for Non-Current Assets was $404479.0 in Q1 2026, with the low at $6674.0 in Q4 2022.
- The 5-year median for Non-Current Assets is $270957.0 (2024), against an average of $226154.0.
- The sharpest annual moves came in 2023 and 2025: Non-Current Assets soared 2927.03% in 2023, then dropped 22.6% in 2025.
- Nexalin Technology's Non-Current Assets stood at $6674.0 in 2022, then jumped by 2927.03% to $202024.0 in 2023, then climbed by 29.49% to $261591.0 in 2024, then rose by 28.46% to $336049.0 in 2025, then rose by 20.36% to $404479.0 in 2026.
- Business Quant data shows NXL's Non-Current Assets at $404479.0 in Q1 2026, $336049.0 in Q4 2025, and $308562.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non-Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 199.49 Bn | 193.88 Bn | 7.27 Bn | 84.70 Bn |
| 2 | Stryker | 127.80 Bn | 124.32 Bn | 4.50 Bn | 33.51 Bn |
| 3 | Medtronic | 118.98 Bn | 109.76 Bn | 6.41 Bn | 68.24 Bn |
| 4 | Boston Scientific | 73.58 Bn | 73.04 Bn | 3.85 Bn | 37.24 Bn |
| 5 | Edwards Lifesciences | 51.93 Bn | 47.68 Bn | 1.35 Bn | 7.05 Bn |
| 6 | Dexcom | 34.34 Bn | 32.39 Bn | 830.00 Mn | 2.37 Bn |
| 7 | GE HealthCare Technologies | 33.76 Bn | 31.66 Bn | 2.18 Bn | 26.75 Bn |
| 8 | Koninklijke Philips | 26.37 Bn | 23.05 Bn | 4.55 Bn | 20.19 Bn |
| 9 | Steris | 23.07 Bn | 22.59 Bn | 684.20 Mn | 8.29 Bn |
| 10 | Nexalin Technology | 7.01 Mn | 6.00 Mn | 8,897.00 | 1.14 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 1.14 Mn |
| Mar 31, 2026 | 404,479.00 |
| Dec 31, 2025 | 336,049.00 |
| Sep 30, 2025 | 308,562.00 |
| Jun 30, 2025 | 294,871.00 |
| Mar 31, 2025 | 279,520.00 |
| Dec 31, 2024 | 261,591.00 |
| Sep 30, 2024 | 349,593.00 |
| Jun 30, 2024 | 380,983.00 |
| Mar 31, 2024 | 270,957.00 |
| Dec 31, 2023 | 202,024.00 |
| Sep 30, 2023 | 170,418.00 |
| Jun 30, 2023 | 63,737.00 |
| Mar 31, 2023 | 54,704.00 |
| Dec 31, 2022 | 6,674.00 |
| Sep 30, 2022 | 8,148.00 |
| Dec 31, 2021 | 1,039.00 |